Copyright
©The Author(s) 2016.
Figure 4 Modeled prevalence (not exclusive1) of hepatitis C virus infection by 6-year period, Libya, 2008-2055.
1Estimates assume stable risk populations and HCV infection risks and do not adjust for treatment. HCV: Hepatitis C virus.
- Citation: Daw MA, Shabash A, El-Bouzedi A, Dau AA, Habas M, Libyan Study Group of Hepatitis and HIV. Modelling the prevalence of hepatitis C virus amongst blood donors in Libya: An investigation of providing a preventive strategy. World J Virol 2016; 5(1): 14-22
- URL: https://www.wjgnet.com/2220-3249/full/v5/i1/14.htm
- DOI: https://dx.doi.org/10.5501/wjv.v5.i1.14